Targeting molecular pathways in endometrial cancer: a focus on the FGFR pathway

Cancer Treatment Reviews
Paula S Lee, Angeles Alvarez Secord

Abstract

In the majority of cases, endometrial cancer is localized and highly curable through surgery and adjuvant radiotherapy. However, for patients with advanced or metastatic disease, prognosis is poor. Systemic treatments such as cytotoxic chemotherapy or hormonal therapy can cause significant toxicities including chemotherapy-related gastrointestinal, neurologic, and immunosuppressive toxicities and hormone-related hypertension, increased blood sugar, thrombosis, and pulmonary emboli. In addition, these therapies rarely lead to sustained disease control. Novel therapies with greater efficacy and reduced toxicity are needed. Recent progress in the identification of genetic abnormalities in cell signaling proteins has spurred the development of targeted agents for the treatment of patients with endometrial cancer. The fibroblast growth factor receptor (FGFR) pathway is one of several signaling pathways that have been implicated in the pathogenesis and progression of endometrial cancer. The activity of novel FGFR-targeted agents in preclinical endometrial cancer models and clinical trials will be reviewed.

References

Feb 1, 1983·Gynecologic Oncology·J V Bokhman
Jun 21, 1996·The Journal of Biological Chemistry·D M OrnitzM Goldfarb
Jan 1, 1996·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·J FujimotoT Tamaya
Jun 8, 2000·Journal of the National Cancer Institute·G L MutterC Eng
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·K YuD M Ornitz
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·O A IbrahimiM Mohammadi
Jun 20, 2002·Endocrinology·Shaw-Jenq TsaiLih-Yuh C Wing
Oct 3, 2002·American Journal of Medical Genetics·Andrew O M WilkieBen C J Hamel
Dec 31, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jay Y ChoWilliam A Horton
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian M SlomovitzKaren H Lu
May 3, 2005·Cytokine & Growth Factor Reviews·Marco PrestaMarco Rusnati
Dec 3, 2005·Cancer Research·Katsutoshi OdaFrank McCormick
Oct 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan L Hecht, George L Mutter
Dec 8, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C E HumberJ A Green
Dec 18, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lluis CatasusJaime Prat
Dec 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aparna A KamatAnil K Sood
Jun 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Amit DuttHeidi Greulich
Feb 5, 2009·Endocrine-related Cancer·Parvesh Chaudhry, Eric Asselin
Mar 11, 2009·Gynecologic Oncology·Monica Prasad HayesLora Hedrick Ellenson
Jun 11, 2009·Current Cancer Drug Targets·M Korc, R E Friesel
Oct 21, 2009·DNA and Cell Biology·Darina KonstantinovaVanio Mitev
Nov 13, 2009·Climacteric : the Journal of the International Menopause Society·J H Pickar
Feb 12, 2010·Obstetrics and Gynecology International·Flora ZagouriChristos A Papadimitriou
Mar 23, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Roshani R PatelV Craig Jordan
Apr 17, 2010·Obstetrics and Gynecology International·Tsuyoshi OkudaTakashi Okai
Jan 12, 2011·Nature Reviews. Clinical Oncology·Konstantin J DedesJorge S Reis-Filho
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carol AghajanianKimberly K Leslie
Jul 2, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Katrin M SjoquistMichael L Friedlander
Jan 26, 2012·Biochimica Et Biophysica Acta·Imran AhmadHing Y Leung
Oct 13, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Sara A ByronPamela M Pollock
May 3, 2013·Nature·Cyriac KandothDouglas A Levine
Jan 2, 2014·Obstetrics and Gynecology International·Xiangbing MengKimberly K Leslie

❮ Previous
Next ❯

Citations

Sep 25, 2014·Frontiers in Chemistry·Konstantinos M KasiotisSerkos A Haroutounian
Mar 29, 2018·Cold Spring Harbor Molecular Case Studies·Jatinder DhamiLorna Rodriguez-Rodriguez
Aug 5, 2017·Viruses·Tamara R LitwinNicolas Wentzensen
Dec 22, 2019·Journal of Cellular and Molecular Medicine·Agnieszka ZaczekAnna Krześlak

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Sara A ByronPamela M Pollock
© 2021 Meta ULC. All rights reserved